Bovine mastitis is a medical condition that is common in dairy cows. It refers to the inflammation of mammary gland and udder tissue. The disease can cause harm to the milk-secreting tissues in cows, which is one of the main reasons, it is considered as a dangerous condition. The increased global incidence of bovine mastitis is expected to have a positive impact on the overall market growth over the forecast period. When mastitis is discovered, the first aid is to apply ice cubes to the udder surface. Infected milk from diseased teats should be drained three times a day and disposed properly. To ensure hygienic disposal, a 5% phenol solution can be added to the infected milk.
Global bovine mastitis market is estimated to be valued at US$ 1,423.5 Million in 2022 and is expected to reach US$ 2,134.3 Million by 2030, at a CAGR of 5.2% during the forecast period (2022-2030).
Figure 1. Global Bovine Mastitis Market Share (%), By Region, 2022
Rising incidence of bovine mastitis is expected to drive the market growth over the forecast period.
The increasing incidence of bovine mastitis is expected to drive the market growth over the forecast period For instance, the global incidence of bovine mastitis ranges between 0 and 200 cows, according to the Cornell University College of Veterinary Medicine. Furthermore, the University of Glasgow estimates that bovine mastitis will cost between US$19.7 billion and $ 30 billion in annual healthcare costs, globally. Moreover, rising prevalence of bovine mastitis infections during the dry season, as well as the increased benefits of non-antibiotic intramammary products such as Teat Sealants in preventing new intramammary infections during the dry season, are expected to drive the market growth.
|Base Year:||2021||Market Size in 2022:||US$ 1,423.5 Mn|
|Historical Data for:||2017 to 2020||Forecast Period:||2022 to 2030|
|Forecast Period 2022 to 2030 CAGR:||5.2%||2030 Value Projection:||US$ 2,134.3 Mn|
Zoetis, Merck & Co., Inc., Boehringer Ingelheim International GmbH, Bayer AG, Elanco, Ceva, West Way Health, Norbrook, DeLaval, ImmuCell Corporation, Advanced Animal Diagnostics, and Nimrod Veterinary Products Ltd.
|Restraints & Challenges:||
Figure 2. Global Bovine Mastitis Market Share (%), By Therapy, 2022
Increasing product launches for animal healthcare is expected to boost the market growth during the forecast period.
Cows are more susceptible to mastitis during dry off due to the environmental and physiological changes they go through. Because keratin plug growth changes throughout the dry period, a cow's natural barrier against new intramammary infections, pathogen risk is higher. When dry cows are exposed to high levels of environmental infections, National Mastitis Council's Recommended Mastitis Control Program recommends using a teat sealant. For instance, in February 2020 Merck & Co. Inc. announced the launch of Shut Out, a sterile, antibiotic-free barrier and a novel teat sealant solution. The product is intended to be used prior to dry off, in order to help avoid intramammary infections.
Global Bovine Mastitis Market– Impact of Coronavirus (COVID-19) Pandemic
Since the COVID-19 virus outbreak in December 2019, the disease has spread to over 100 countries across the globe and the World Health Organization declared it as a public health emergency in 2020. According to the Coronavirus Disease (COVID-19) Weekly Epidemiological Update by the World Health Organization, the number of COVID-19 cases reported globally as of August 2, 2021 are approximately 198,234,951 confirmed cases with around 4,227,359 deaths. The coronavirus or COVID-19 outbreak started from Wuhan, China and has spread across continents, affecting various industries globally.
Even during the epidemic, despite lockdown and social distancing procedures, the persistent demand for dairy products has surfaced in favor of the market growth. Moreover, as these products fall under the category of essential services, the market is estimated to grow rapidly during the forecast period.
Global Bovine Mastitis Market: Restraint
The increasing antibiotic resistance and lack of awareness about the bovine mestitis disease are the major factors that are expected to hinder growth of the global bovine mastitis market.
Major players operating in the global bovine mastitis market include Zoetis, Merck & Co., Inc., Boehringer Ingelheim International GmbH, Bayer AG, Elanco, Ceva, West Way Health, Norbrook, DeLaval, ImmuCell Corporation, Advanced Animal Diagnostics, and Nimrod Veterinary Products Ltd.
Bovine mastitis is characterized by a prolonged and inflammatory response of the udder tissue, as a result of either physical trauma or microorganism-caused illnesses. It is a life threatening mammary gland infection that is most prevalent in dairy cows globally. It's a condition known for causing damage on the dairy industry's profit margin. Mastitis is caused by a huge number of different microorganism species. Viruses, mycoplasmas, fungi, and bacteria are among them. Mastitis manifests itself as a red, hardened lump in the udder. The enlarged mammary gland is extremely hot, and even touching it causes pain and discomfort in animals. To avoid milking, animals will not touch or kick the udder. Blood clots, foul-smelling brown discharge, and milk clots are common in this condition.
Milk production comes to a halt or is seriously hampered as the animal's internal temperature rises. Lack of appetite, mobility issues due to a bloated udder, and soreness are some of the other symptoms of bovine mestitis. Sunken eyes, intestinal problems, and diarrhoea are all symptoms among dairy animals suffering from bovine mestitis. California Mastitis Test (CMT) can diagnose mastitis at an early stage (sub-clinical) before symptoms occur. It is a simple test that may be done on little amount of milk. Early identification aids in preventing the disease from progressing to clinical stages, which would result in significant losses for dairy farmers.
One of the primary factors driving the global bovine mastitis market expansion include increasing prevalence of bovine mastitis across the world. For instance, according to an article published by the US National Library of Medicine and National Institutes of Health in August 2020, at the quarter, cow, and farm level, the overall prevalence of clinical and subclinical mastitis was 51.6% (815/1,580), 74.4% (294/395), and 76.6% (118/154), respectively.
Key features of the study:
“*” marked represents similar segmentation in other categories in the respective section.